Jundishapur Journal of Natural Pharmaceutical Products

Published by: Kowsar

A Comparison of the Effects of Quercetin Hydrate With Those of Vitamin E on the Levels of IL-13, PDGF, TNF-α, and INF-γ in Bleomycin-Induced Pulmonary Fibrosis in Rats

Ali Reza Malayeri 1 , Ali Asghar Hemmati 1 , * , Ardeshir Arzi 2 , Annahita Rezaie 3 , Mehri Ghafurian-Boroojerdnia 4 and Hamid Reza Khalili 1
Authors Information
1 Department of Pharmacology and Toxicology, Medicinal Plants and Natural Products Research Center, School of Pharmacy, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, IR Iran
2 Department of Pharmacology and Toxicology, Physiology Research Center, School of Pharmacy, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, IR Iran
3 Department of Pathology, Faculty of Veterinary Medicine, Shahid Chamran University, Ahvaz, IR Iran
4 Department of Immunology, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, IR Iran
Article information
  • Jundishapur Journal of Natural Pharmaceutical Products: May 01, 2016, 11 (2); e27705
  • Published Online: April 23, 2016
  • Article Type: Research Article
  • Received: February 4, 2015
  • Revised: July 25, 2015
  • Accepted: January 23, 2016
  • DOI: 10.17795/jjnpp-27705

To Cite: Malayeri A R, Hemmati A A, Arzi A, Rezaie A, Ghafurian-Boroojerdnia M, et al. A Comparison of the Effects of Quercetin Hydrate With Those of Vitamin E on the Levels of IL-13, PDGF, TNF-α, and INF-γ in Bleomycin-Induced Pulmonary Fibrosis in Rats, Jundishapur J Nat Pharm Prod. 2016 ; 11(2):e27705. doi: 10.17795/jjnpp-27705.

Copyright © 2016, School of Pharmacy, Ahvaz Jundishapur University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Materials and Methods
4. Results
5. Discussion
  • 1. Arts MJ, Sebastiaan Dallinga J, Haenen GR. A new approach to assess the total antioxidant capacity using the TEAC assay. Food Chem. 2004; 88(4): 567-70[DOI]
  • 2. Wattel A, Kamel S, Prouillet C, Petit JP, Lorget F, Offord E, et al. Flavonoid quercetin decreases osteoclastic differentiation induced by RANKL via a mechanism involving NF kappa B and AP-1. J Cell Biochem. 2004; 92(2): 285-95[DOI][PubMed]
  • 3. Kim YJ, Bae YC, Suh KT, Jung JS. Quercetin, a flavonoid, inhibits proliferation and increases osteogenic differentiation in human adipose stromal cells. Biochem Pharmacol. 2006; 72(10): 1268-78[DOI][PubMed]
  • 4. Vieira EK, Bona S, Di Naso FC, Porawski M, Tieppo J, Marroni NP. Quercetin treatment ameliorates systemic oxidative stress in cirrhotic rats. ISRN Gastroenterol. 2011; 2011: 604071[DOI][PubMed]
  • 5. Chen X. Protective effects of quercetin on liver injury induced by ethanol. Pharmacogn Mag. 2010; 6(22): 135-41[DOI][PubMed]
  • 6. Knekt P, Kumpulainen J, Jarvinen R, Rissanen H, Heliovaara M, Reunanen A, et al. Flavonoid intake and risk of chronic diseases. Am J Clin Nutr. 2002; 76(3): 560-8[PubMed]
  • 7. Hemmati AA, Rezaie A, Darabpour P. Preventive effects of pomegranate seed extract on bleomycin-induced pulmonary fibrosis in rat. Jundishapur J Nat Pharm Prod. 2013; 8(2): 76-80[PubMed]
  • 8. Richeldi L, Davies HRHR, Spagnolo P, Luppi F, Richeldi L. Corticosteroids for idiopathic pulmonary fibrosis. 2003; [DOI]
  • 9. Chen F, Gong L, Zhang L, Wang H, Qi X, Wu X, et al. Short courses of low dose dexamethasone delay bleomycin-induced lung fibrosis in rats. Eur J Pharmacol. 2006; 536(3): 287-95[DOI][PubMed]
  • 10. Demedts M, Costabel U. ATS/ERS international multidisciplinary consensus classification of the idiopathic interstitial pneumonias. Eur Respir J. 2002; 19(5): 794-6[PubMed]
  • 11. Kim DS, Collard HR, King TJ. Classification and natural history of the idiopathic interstitial pneumonias. Proc Am Thorac Soc. 2006; 3(4): 285-92[DOI][PubMed]
  • 12. Kuwano K, Kunitake R, Maeyama T, Hagimoto N, Kawasaki M, Matsuba T, et al. Attenuation of bleomycin-induced pneumopathy in mice by a caspase inhibitor. Am J Physiol Lung Cell Mol Physiol. 2001; 280(2)-25[PubMed]
  • 13. Adamson IY. Pulmonary toxicity of bleomycin. Environ Health Perspect. 1976; 16: 119-26[PubMed]
  • 14. Umezawa H, Ishizuka M, Maeda K, Takeuchi T. Studies on bleomycin. Cancer. 1967; 20(5): 891-5
  • 15. Sleijfer S. Bleomycin-induced pneumonitis. CHEST J. 2001; 120(2): 617-24
  • 16. Border WA, Noble NA. Transforming growth factor beta in tissue fibrosis. N Engl J Med. 1994; 331(19): 1286-92[DOI][PubMed]
  • 17. Abdollahi A, Li M, Ping G, Plathow C, Domhan S, Kiessling F, et al. Inhibition of platelet-derived growth factor signaling attenuates pulmonary fibrosis. J Exp Med. 2005; 201(6): 925-35[DOI][PubMed]
  • 18. Aliprantis AO, Wang J, Fathman JW, Lemaire R, Dorfman DM, Lafyatis R, et al. Transcription factor T-bet regulates skin sclerosis through its function in innate immunity and via IL-13. Proc Natl Acad Sci U S A. 2007; 104(8): 2827-30[DOI][PubMed]
  • 19. Hasegawa M, Fujimoto M, Kikuchi K, Takehara K. Elevated serum tumor necrosis factor-alpha levels in patients with systemic sclerosis: association with pulmonary fibrosis. J Rheumatol. 1997; 24(4): 663-5[PubMed]
  • 20. Moutsatsou P. The spectrum of phytoestrogens in nature: our knowledge is expanding. Hormones (Athens). 2007; 6(3): 173-93[PubMed]
  • 21. Cortijo J, Cerda-Nicolas M, Serrano A, Bioque G, Estrela JM, Santangelo F, et al. Attenuation by oral N-acetylcysteine of bleomycin-induced lung injury in rats. Eur Respir J. 2001; 17(6): 1228-35[PubMed]
  • 22. Wang HD, Yamaya M, Okinaga S, Jia YX, Kamanaka M, Takahashi H, et al. Bilirubin ameliorates bleomycin-induced pulmonary fibrosis in rats. Am J Respir Crit Care Med. 2002; 165(3): 406-11[DOI][PubMed]
  • 23. Kilinc C, Ozcan O, Karaoz E, Sunguroglu K, Kutluay T, Karaca L. Vitamin E reduces bleomycin-induced lung fibrosis in mice: biochemical and morphological studies. J Basic Clin Physiol Pharmacol. 1993; 4(3): 249-69[PubMed]
  • 24. Daba MH, Abdel-Aziz AA, Moustafa AM, Al-Majed AA, Al-Shabanah OA, El-Kashef HA. Effects of L-carnitine and ginkgo biloba extract (EG b 761) in experimental bleomycin-induced lung fibrosis. Pharmacol Res. 2002; 45(6): 461-7[PubMed]
  • 25. Larki-Harchegani A, Hemmati AA, Arzi A, Ghafurian-Boroojerdnia M, Shabib S, Zadkarami MR, et al. Evaluation of the Effects of Caffeic Acid Phenethyl Ester on Prostaglandin E2 and Two Key Cytokines Involved in Bleomycin-induced Pulmonary Fibrosis. Iran J Basic Med Sci. 2013; 16(7): 850-7[PubMed]
  • 26. Schraufnagel DE, Mehta D, Harshbarger R, Treviranus K, Wang NS. Capillary remodeling in bleomycin-induced pulmonary fibrosis. Am J Pathol. 1986; 125(1): 97-106[PubMed]
  • 27. Giri SN, Hyde DM, Nakashima JM. Analysis of bronchoalveolar lavage fluid from bleomycin-induced pulmonary fibrosis in hamsters. Toxicol Pathol. 1986; 14(2): 149-57[PubMed]
  • 28. Fell CD, Martinez FJ, Liu LX, Murray S, Han MK, Kazerooni EA, et al. Clinical predictors of a diagnosis of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2010; 181(8): 832-7[DOI][PubMed]
  • 29. Vyalov SL, Gabbiani G, Kapanci Y. Rat alveolar myofibroblasts acquire alpha-smooth muscle actin expression during bleomycin-induced pulmonary fibrosis. Am J Pathol. 1993; 143(6): 1754-65[PubMed]
  • 30. Costabel U, King TE. International consensus statement on idiopathic pulmonary fibrosis. Eur Respir J. 2001; 17(2): 163-7[PubMed]
  • 31. Gogali A, Wells AU. New pharmacological strategies for the treatment of pulmonary fibrosis. Ther Adv Respir Dis. 2010; 4(6): 353-66[DOI][PubMed]
  • 32. Chiaramonte MG, Cheever AW, Malley JD, Donaldson DD, Wynn TA. Studies of murine schistosomiasis reveal interleukin-13 blockade as a treatment for established and progressive liver fibrosis. Hepatology. 2001; 34(2): 273-82[DOI][PubMed]
  • 33. Zhu Z, Homer RJ, Wang Z, Chen Q, Geba GP, Wang J, et al. Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production. J Clin Invest. 1999; 103(6): 779-88[DOI][PubMed]
  • 34. Raghu G, Brown KK, Costabel U, Cottin V, du Bois RM, Lasky JA, et al. Treatment of idiopathic pulmonary fibrosis with etanercept: an exploratory, placebo-controlled trial. Am J Respir Crit Care Med. 2008; 178(9): 948-55[DOI][PubMed]
  • 35. Ziesche R, Hofbauer E, Wittmann K, Petkov V, Block LH. A preliminary study of long-term treatment with interferon gamma-1b and low-dose prednisolone in patients with idiopathic pulmonary fibrosis. N Engl J Med. 1999; 341(17): 1264-9[DOI][PubMed]
  • 36. Tulek B, Kiyan E, Toy H, Kiyici A, Narin C, Suerdem M. Anti-inflammatory and anti-fibrotic effects of sirolimus on bleomycin-induced pulmonary fibrosis in rats. Clin Invest Med. 2011; 34(6)[PubMed]
  • 37. Zhou C, Han W, Zhang P, Cai M, Wei D, Zhang C. Lycopene from tomatoes partially alleviates the bleomycin-induced experimental pulmonary fibrosis in rats. Nutr Res. 2008; 28(2): 122-30[DOI][PubMed]
  • 38. Tulek B, Kiyan E, Kiyici A, Toy H, Bariskaner H, Suerdem M. Effects of simvastatin on bleomycin-induced pulmonary fibrosis in female rats. Biol Res. 2012; 45(4): 345-50[DOI][PubMed]
  • 39. Bjeldanes LF, Chang GW. Mutagenic activity of quercetin and related compounds. Science. 1977; 197(4303): 577-8[PubMed]
  • 40. Boots AW, Haenen GR, Bast A. Health effects of quercetin: from antioxidant to nutraceutical. Eur J Pharmacol. 2008; 585(2-3): 325-37[DOI][PubMed]
  • 41. Haenen GR, Bast A. Nitric oxide radical scavenging of flavonoids. Methods Enzymol. 1999; 301: 490-503[PubMed]
  • 42. Baowen Q, Yulin Z, Xin W, Wenjing X, Hao Z, Zhizhi C, et al. A further investigation concerning correlation between anti-fibrotic effect of liposomal quercetin and inflammatory cytokines in pulmonary fibrosis. Eur J Pharmacol. 2010; 642(1-3): 134-9[DOI][PubMed]
  • 43. Park HK, Kim SJ, Kwon do Y, Park JH, Kim YC. Protective effect of quercetin against paraquat-induced lung injury in rats. Life Sci. 2010; 87(5-6): 181-6[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments